The loperamide inhibits bladder cancer cell proliferation by inducing autophagy and apoptosis through the ROS-mediated JNK pathway, and combining loperamide with autophagy inhibitor CQ enhances its anti-cancer effects. This evidence concerns the gene MAPK8 and urinary bladder cancer.